Literature DB >> 22555127

Delayed posthypoxic leukoencephalopathy following a morphine overdose.

R Salazar1, J Dubow.   

Abstract

We describe one patient and review the literature to define delayed posthypoxic leukoencephalopathy, its etiology, pathophysiology and prognosis. We present a 54-year-old man with confusion and diffuse rigidity following a morphine overdose that had required intubation three weeks previously. A brain CT scan showed bilateral globi pallidi hypodensities and diffusion-weighted brain MRI (DWI) was consistent with acute cerebral anoxia. On day 20 after the initial presentation, the patient insidiously progressed to a state of "akinetic mutism". The brain MRI showed diffuse hyperintensity of the white matter on T2-weighted fluid-attenuated inversion recovery sequences. These areas were bright on DWI and were hypointense on the apparent diffusion coefficient map. An extensive autoimmune, metabolic, toxicological, and infectious work-up included arylsulfatase A enzyme levels, which were unremarkable. Therapy with levodopa was initiated with subsequent improvement of the diffuse rigidity. At discharge, the patient continued to be lethargic with moderate rigidity but began to display signs of recovery. He eventually fully recovered with residual mild confusion. Thus, delayed hypoxic leukoencephalopathy is a rare complication of hypoxic-ischemic encephalopathy, occurring in 2.75% of victims of carbon monoxide poisoning. It typically manifests two to 40 days after apparent recovery from an obtunded state. Prognosis is variable, but recovery can be complete. This report brings to light an important syndrome that can easily be misdiagnosed. Patients who present with these clinical and radiographic features should be treated fully and given time to recover without abrupt withdrawal of care.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22555127     DOI: 10.1016/j.jocn.2012.01.001

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  8 in total

1.  The molecular neurobiology and neuropathology of opioid use disorder.

Authors:  Christopher A Blackwood; Jean Lud Cadet
Journal:  Curr Res Neurobiol       Date:  2021-10-14

Review 2.  Delayed posthypoxic leukoencephalopathy: a case series and review of the literature.

Authors:  Carlos A Zamora; David Nauen; Robert Hynecek; Ahmet T Ilica; Izlem Izbudak; Haris I Sair; Sachin K Gujar; Jay J Pillai
Journal:  Brain Behav       Date:  2015-07-03       Impact factor: 2.708

Review 3.  Acute fatal posthypoxic leukoencephalopathy following benzodiazepine overdose: a case report and review of the literature.

Authors:  Salman Aljarallah; Fawaz Al-Hussain
Journal:  BMC Neurol       Date:  2015-04-30       Impact factor: 2.474

4.  Delayed posthypoxic leukoencephalopathy following alcohol and psychotropic drug overdose: a case report.

Authors:  Kanji Ueno; Tetsuya Takahashi; Masato Higashima; Ryoko Okazaki; Seiichiro Takano; Yuji Wada
Journal:  Clin Case Rep       Date:  2018-05-02

5.  Delayed Post-hypoxic Leukoencephalopathy (DPHL)-An Uncommon Variant of Hypoxic Brain Damage in Adults.

Authors:  Anne B Beeskow; Moritz Oberstadt; Dorothee Saur; Karl-Titus Hoffmann; Donald Lobsien
Journal:  Front Neurol       Date:  2018-08-27       Impact factor: 4.003

6.  Outcomes associated with hospital admissions for accidental opioid overdose in British Columbia: a retrospective cohort study.

Authors:  Richard L Morrow; Ken Bassett; Malcolm Maclure; Colin R Dormuth
Journal:  BMJ Open       Date:  2019-05-05       Impact factor: 2.692

7.  Delayed Posthypoxic Leukoencephalopathy: Improvement with Antioxidant Therapy.

Authors:  Franklin King; Nicholas A Morris; Jeremy D Schmahmann
Journal:  Case Rep Neurol       Date:  2015-12-24

Review 8.  Neurocognitive impairments and brain abnormalities resulting from opioid-related overdoses: A systematic review.

Authors:  Erin L Winstanley; James J Mahoney; Felipe Castillo; Sandra D Comer
Journal:  Drug Alcohol Depend       Date:  2021-06-24       Impact factor: 4.492

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.